HHS Secretary Kathleen Sebelius has announced the award of $17 million to fund projects to fight costly and dangerous healthcare-associated infections (HAIs).
"When patients go to the hospital, they expect to get better, not worse," Sebelius said. "Eliminating infections is critical to making care safer for patients and to improving the overall quality and safety of the healthcare system. We know that it can be done, and this new initiative will help us reach our goal."
HAIs are one of the most common complications of hospital care. Nearly 2 million patients develop HAIs, which contribute to 99,000 deaths each year and $28 billion to $33 billion in healthcare costs. HAIs are caused by different types of bacteria that infect patients being treated in a hospital or health care setting for other conditions. The most common HAI-causing bacteria is methicillin-resistant Staphylococcus aureus (MRSA). The number of MRSA-associated hospital stays has more than tripled since 2000, reaching 368,600 in 2005, according to HHS' Agency for Healthcare Research and Quality's (AHRQ) Healthcare Cost and Utilization Project.
Of the $17 million, $8 million will fund a national expansion of the Keystone Project, which within 18 months successfully reduced the rate of central-line bloodstream infections in more than 100 Michigan intensive care units and saved 1,500 lives and $200 million. The project was originally started by the Johns Hopkins University in Baltimore and the Michigan Health & Hospital Association to implement a comprehensive unit-based safety program. The program involves using a checklist of evidence-based safety practices; staff training and other tools for preventing infections that can be implemented in hospital units; standard and consistent measurement of infection rates; and tools to improve teamwork among doctors, nurses and hospital leaders.
Last year, AHRQ funded an expansion of this project to 10 states. With additional funding from AHRQ and a private foundation, the Keystone Project is now operating in all 50 states, Puerto Rico and the District of Columbia. The new funding announced today will expand the effort to more hospitals, extend it to other settings in addition to ICUs, and broaden the focus to address other types of infections. Specifically, the new $8 million in funding will provide:
-- $6 million to the Health Research & Educational Trust for national efforts to expand the Comprehensive Unit-Based Patient Safety Program to Reduce Central Line-Associated Blood Stream Infections. The funding will allow more hospitals in all 50 states to participate in the program and expand the program's reach into hospital settings outside of the ICU. The Health Research & Educational Trust will also use $1 million to support a demonstration project that will help fight catheter-associated urinary tract infections.
-- $1 million to Yale University to support a comprehensive plan to prevent bloodstream infections in hemodialysis patients.
AHRQ, in collaboration with the Centers for Disease Control and Prevention (CDC), also identified several high-priority areas to apply the remaining $9 million toward reducing MRSA and other types of HAIs. These projects will focus on:
-- Reducing Clostridium difficile infections through a regional hospital collaborative.
-- Reducing the overuse of antibiotics by primary care clinicians treating patients in ambulatory and long-term care settings.
-- Evaluating two ways to eliminate MRSA in ICUs.
-- Improving the measurement of the risk of infections after surgery.
-- Identifying national-, regional- and state-level rates of HAIs that are acquired in the acute care setting.
-- Reducing infections caused by Klebsiella pneumoniae Carbapenemase-producing organisms by applying recently developed recommendations from CDC's Healthcare Infection Control Practices Advisory Committee.
-- Standardizing antibiotic use in long-term care settings (two projects).
-- Implementing teamwork principles for frontline healthcare providers.
A complete list of institutions funded by the $17 million in resources awarded is available at http://www.ahrq.gov/qual/haify09.htm.
Source: Agency for Healthcare Research & Quality
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Infection Intel: Augmenting SHIELD WALL Modular Containment Systems by Abatement Technologies
August 8th 2024Jackie Otero, senior territory sales representative at Abatement Technologies, discusses the SHIELD WALL modular containment system by Abatement Technologies, highlighting its quick assembly, durability, noise reduction, and benefits in maintaining indoor air quality in health care settings.
Phage Therapy: The Future of Bacterial Infection Treatment?
August 7th 2024Rising antibiotic resistance necessitates exploring phage therapy as an alternative. Despite historical sidelining, phages show promise in treating various infections, but regulatory, safety, and resistance challenges remain.